RxDoctor Payments Data

Manal Anz, DPM

Foot Surgery · Shelton, CTNPI 1285946426

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $2,220 of the $3,640 with a category attached, or 61.0%. 8 manufacturers reported payments, led by Stryker at 41.1% of the total. Reporting peaked in 2019 at $3,291 and has fallen 98.6% since, to $45 in 2025.

$3,640in general payments, 2019–2025

Across 39 payments — averaging $93.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$1K
  • Arthrosurface Incorporated$1K
  • KCI USA, Inc.$373
  • Organogenesis Inc.$268
  • Smith+Nephew$257
  • Kerecis Limited$46
  • plus $45 from 2 others

What the payments were for

  • Speaking & faculty fees$1253%
  • Travel & lodging$2,22061%
  • Food & beverage$1,29536%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stryker12$1,497
Arthrosurface Incorporated8$1,155
KCI USA, Inc.1$373
Organogenesis Inc.4$268
Smith+Nephew11$257
Kerecis Limited1$46
Hydrofera LLC1$23
Lifenet Health1$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,640 in reported general payments places this provider in the 85th percentile of 20 foot surgery providers in Connecticut.

See all foot surgery providers in Connecticut

Medicare billing

Part B allowed, 2024
$36,384
Medicare patients
149
Services billed
584

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CiclopiroxCiclopirox Olamine42$809
Clindamycin Phosphate17$571
Ketoconazole30$457
Ammonium Lactate35$376
Ciclopirox20$321
Mupirocin34$260

Paid to pharmacies, not to this prescriber.

Other foot surgery in Shelton

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →